Pathogen Definition, Types, Examples and Disease Mechanisms

In simple terms: a pathogen is an infectious microbe or particle that can make a host sick. The term is most often used for human disease, but pathogens also infect animals, plants and other organisms.

Pathogenicity is not always a fixed property of a microbe. The same organism may be harmless in one body site or host and harmful in another. Disease depends on the pathogen, the host's immune state, the dose, the route of exposure and the surrounding microbial community. This is why modern microbiology defines pathogens through the outcome of the host-microbe interaction, not simply by taxonomy.

Several terms describe the relationship between a microbe and its host, and they are not interchangeable. A commensal lives on or in the host without causing harm, and many resident microbes of the human microbiome are commensals. A pathogen can cause disease, but whether it does so in a given host depends on context.

The boundary between commensal and pathogen is therefore permeable. Escherichia coli, for example, is a routine resident of the human colon but can cause severe disease when it acquires virulence genes or reaches the urinary tract or bloodstream.

Pathogens are grouped by their fundamental biology because cellular structure determines how they replicate, how they cause damage and which drugs can target them.

Bacteria are single-celled prokaryotes with their own machinery for transcription, translation and metabolism. Antibacterial drugs often exploit bacterial features, such as the cell wall or the bacterial ribosome, that differ from those of human cells.

Viruses are not cells. They consist of a nucleic acid genome – DNA or RNA – packaged in a protein coat, sometimes wrapped in a lipid envelope. They replicate only inside host cells, which makes antiviral drug design challenging because many steps of replication depend on host machinery.

Fungi are eukaryotes and are therefore more closely related to humans than bacteria are. Parasites range from single-celled protozoa such as Plasmodium, the cause of malaria, to multicellular worms. Prions are unusual infectious agents made of misfolded protein rather than nucleic acid, and they cause fatal neurodegenerative diseases by inducing normal host proteins to misfold.

Pathogens usually cause disease through a sequence of steps: entry into the host, attachment to a tissue, colonization or replication, evasion of host defenses and production of damage. These steps are mediated by virulence factors. Bacterial virulence factors include adhesins that bind host cells, toxins that disrupt host processes and secretion systems that inject effector proteins into host cells.

Viruses cause disease by entering cells, redirecting cellular machinery toward viral replication and damaging tissues either directly or through immune-mediated inflammation. Fungal and parasitic pathogens use diverse strategies, including tissue invasion, immune evasion, nutrient theft and long-term persistence. In many infections, symptoms arise from both the pathogen and the host's inflammatory response to it.

Why one person develops severe disease from an infection while another remains well is a central question in pathogen biology. The damage-response framework, introduced by Arturo Casadevall and Liise-anne Pirofski in 2003 in Nature Reviews Microbiology, recast microbial pathogenesis as the integrated outcome of host-microbe interactions. In this view, disease reflects host damage, and the same encounter can produce no symptoms, mild disease or fatal disease depending on immune state and context.

This framework helps explain opportunistic infections, asymptomatic carriage and immunopathology. A weak immune response can allow uncontrolled pathogen growth, while an excessive immune response can damage host tissues even after pathogen numbers fall. The most useful definition of a pathogen is therefore relational: it describes what a biological agent can do in a particular host under particular conditions.

Identifying the pathogen responsible for an infection is the foundation of clinical microbiology and public-health surveillance. Traditional methods include microscopy, culture, biochemical typing and serology using antibody-based assays. ELISA and lateral-flow tests detect pathogen antigens or the antibodies produced against them.

Molecular methods now play a central role. PCR and other nucleic-acid amplification tests detect pathogen DNA or RNA directly and can be highly sensitive. Genome sequencing can identify new pathogens, track outbreaks and reveal antimicrobial resistance mutations. Metagenomic sequencing is especially useful when clinicians do not know which organism to test for, because it can survey the genetic material in a sample without a pathogen-specific assay.

Antimicrobial resistance is the ability of a pathogen to survive exposure to a drug that previously killed or controlled it. It is one of the defining health challenges of recent decades. A 2022 Lancet analysis of the 2019 global burden estimated 4.95 million deaths associated with bacterial antimicrobial resistance and 1.27 million deaths directly attributable to resistant infections. A 2024 Lancet analysis projected that, under a reference scenario, attributable deaths could rise to roughly 1.9 million annually by 2050.

Resistance evolves because pathogen populations reproduce rapidly and are exposed to strong selection pressure. Resistant variants can arise through mutation or acquire resistance genes from other microbes. Antibiotic overuse in medicine and agriculture, incomplete treatment, poor infection control and slow development of new antimicrobials all contribute to the problem.

Many newly recognized human pathogens originate in other animal species and then cross into people in events known as zoonotic spillovers. SARS, MERS, Ebola, mpox, avian influenza and SARS-CoV-2 are examples. A Nature Reviews Microbiology review published online in 2025 by Reina Sikkema and Marion Koopmans discusses climate change, urbanization, land-use change, intensified livestock production and global travel as drivers that bring people, animals and pathogens into more frequent contact.

Surveillance of emerging pathogens increasingly combines clinical reporting, genome sequencing, wastewater monitoring, wildlife sampling and One Health approaches that connect human, animal and environmental health. Ancient pathogen genomics adds another perspective by reconstructing the long-term evolution of agents such as plague, tuberculosis and variola virus.

For many major infectious diseases, the most powerful interventions are preventive, including vaccination, sanitation, vector control, infection prevention and antimicrobial stewardship. Vaccines train the adaptive immune system to recognize pathogen antigens before infection occurs, and they have eradicated smallpox, controlled poliomyelitis and measles, and reduced deaths from hepatitis B and many bacterial diseases. mRNA vaccines, deployed at scale against COVID-19, showed how quickly vaccine design can proceed once a pathogen sequence is known.

Monoclonal antibodies targeting specific viral or bacterial epitopes have been used or approved for diseases including respiratory syncytial virus, Ebola and COVID-19, although their usefulness against rapidly evolving viruses can change as variants emerge.

Routine sequencing of pathogen isolates has shifted public-health surveillance from describing outbreaks after the fact to tracking pathogens in close to real time. Sequence data can reveal transmission chains, new variants and resistance patterns. Pathogen genomics also supports personalized medicine, because antimicrobial choice can be matched to the resistance profile of the patient's specific isolate.

Pathogen biology has supplied important tools for molecular biology. Restriction enzymes, which bacteria use to cut invading viral DNA, became central to recombinant DNA technology. CRISPR-Cas9 evolved as a bacterial defense against bacteriophages and is now a major genome-editing system. Engineered viral vectors are used in gene therapy and vaccine delivery.

What is the difference between a pathogen and a germ? Germ is an informal word for a microbe that can cause illness. Pathogen is the more precise scientific term for a biological agent, including bacteria, viruses, fungi, parasites and prions, that has the capacity to cause disease in a host.

Are all bacteria pathogens? No. Most bacteria are not pathogenic to humans. Many live in soil, water and other environments, and many are beneficial residents of the human gut, skin and other body sites. Only a minority of bacterial species cause human disease.

What is the difference between infection and disease? Infection means an infectious agent has entered, established itself and, in most cases, is multiplying or persisting in a host. Disease means the infection is producing damage, dysfunction or symptoms. Many infections remain asymptomatic.

What is an opportunistic pathogen? An opportunistic pathogen is a microbe that causes disease mainly when host defenses are weakened, such as in people with advanced age, HIV, cancer chemotherapy or organ transplants. Examples include Candida albicans and Pseudomonas aeruginosa.

How are new pathogens discovered? New pathogens are often identified during outbreaks of unexplained illness, when clinical samples are analyzed using microscopy, culture, immunoassays and sequencing. Metagenomic sequencing is particularly useful because it can detect microbial DNA or RNA without prior knowledge of the agent.

Why is antimicrobial resistance such a concern? Antimicrobial resistance allows pathogens to survive treatments that previously killed or controlled them, making routine infections harder to treat. It is driven by microbial evolution, antimicrobial overuse, transmission of resistant strains and limited development of new drugs.

Nature Reviews Microbiology, The Damage-Response Framework of Microbial Pathogenesis

The Lancet, Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis

The Lancet, Global Burden of Bacterial Antimicrobial Resistance 1990–2021: A Systematic Analysis with Forecasts to 2050

Nature Reviews Microbiology, Viral Emergence and Pandemic Preparedness in a One Health Framework

Nature Reviews Microbiology, Insights into Infectious Diseases through Ancient Pathogen Genomics